NASDAQ:REFR - Research Frontiers Stock Price, Forecast & News

Research Frontiers trades on the NASDAQ under the ticker symbol "REFR."

Research Frontiers, Inc. (NASDAQ:REFR) issued its quarterly earnings results on Thursday, August, 8th. The technology company reported ($0.05) EPS for the quarter. The technology company earned $0.30 million during the quarter. Research Frontiers had a negative return on equity of 52.27% and a negative net margin of 205.08%. View Research Frontiers' Earnings History.

Research Frontiers is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Research Frontiers.

News headlines about REFR stock have trended negative on Saturday, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Research Frontiers earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned news articles about the technology company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the stock's share price in the near future. View News Stories for Research Frontiers.

Some companies that are related to Research Frontiers include Liberty Tax (TAXA), Joint (JYNT), Quarterhill (QTRH), Quarterhill (QTRHF), Acacia Research (ACTG), Finjan (FNJN), XCel Brands (XELB), XpresSpa Group (XSPA), MGT Capital Investments (MGTI), Health Discovery (HDVY), ARC Group (ARCK), Marathon Patent Group (MARA), Spherix (SPEX), American Restaurant Partners LP Class A Partnership Units (ICTPU) and Fortel (ECGP).

Based on aggregate information from My MarketBeat watchlists, some companies that other Research Frontiers investors own include Microvision (MVIS), Energy Transfer LP Unit (ET), Immunomedics (IMMU), Onconova Therapeutics (ONTX), SeaChange International (SEAC), Blackstone Group (BX), Elite Pharmaceuticals (ELTP), Inovio Pharmaceuticals (INO), Nektar Therapeutics (NKTR) and Ford Motor (F).

Research Frontiers' stock is owned by many different of institutional and retail investors. Top institutional investors include Geode Capital Management LLC (0.57%), Shufro Rose & Co. LLC (0.55%), B. Riley Wealth Management Inc. (0.07%) and Jane Street Group LLC (0.04%). Company insiders that own Research Frontiers stock include Alexander Kaganowicz, Darryl Daigle, Gregory George Grimes, Joseph M Harary, Kevin Douglas and Michael R Lapointe. View Institutional Ownership Trends for Research Frontiers.

REFR stock was acquired by a variety of institutional investors in the last quarter, including Jane Street Group LLC, Shufro Rose & Co. LLC, Geode Capital Management LLC and B. Riley Wealth Management Inc.. Company insiders that have bought Research Frontiers stock in the last two years include Alexander Kaganowicz, Darryl Daigle, Joseph M Harary and Kevin Douglas. View Insider Buying and Selling for Research Frontiers.

Shares of REFR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of REFR stock can currently be purchased for approximately $3.81.

Research Frontiers has a market capitalization of $118.45 million and generates $1.49 million in revenue each year. Research Frontiers employs 9 workers across the globe.View Additional Information About Research Frontiers.

The official website for Research Frontiers is http://www.smartglass.com/.

Research Frontiers' mailing address is 240 CROSSWAYS PARK DRIVE, WOODBURY NY, 11797. The technology company can be reached via phone at 516-364-1902 or via email at [email protected]